Patents by Inventor Mandana Sassanfar

Mandana Sassanfar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6221640
    Abstract: Recombinant nucleic acids which encode aminoacyl-tRNA sythetases of enterococcal origin or portions of such enzymes, have been isolated. These nucleic acids can be used to make expression constructs and transformed host cells for the production of enterococcal aminoacyl-tRNA synthetases. They can also be used in the further isolation of nucleic acids related by DNA sequence similarities, which also encode enterococcal aminoacyl-tRNA synthetases, or portions thereof. A further embodiment of the invention is antisense nucleic acid which can hybridize to the nucleic acid which encodes the aminoacyl-tRNA synthetase of enterococci. The invention also relates to tRNA synthetases such as isolated and/or recombinant enterococcal aminoacyl-tRNA synthetases. Antibodies which bind to these enzymes can be made and can be used in the purification and study of the enzymes.
    Type: Grant
    Filed: May 14, 1997
    Date of Patent: April 24, 2001
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Jianshi Tao, Mandana Sassanfar, Paul L. Gallant, Xiaoyu Shen, Anthony S. Avruch, Russell V. Yu, Shamila Nair
  • Patent number: 5885815
    Abstract: The present invention relates to isolated and/or recombinant nucleic acids which encode Candida isoleucyl-tRNA synthetases, portions thereof, or fusion proteins comprising a Candida isoleucyl-tRNA synthetase or portion thereof. Also disclosed are constructs comprising the nucleic acids of the present invention, host cells comprising a recombinant nucleic acid or construct, and methods of producing a Candida isoleucyl-tRNA synthetase, portion thereof, or fusion protein comprising same. Also described are tester strains, which are cells engineered to rely on the function of a Candida isoleucyl-tRNA synthetase or functional fragment thereof encoded by an introduced cloned gene, and which can be used in a method of detecting an inhibitor of Candida isoleucyl-tRNA synthetase function.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: March 23, 1999
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Mandana Sassanfar, Christoph Kaufmann, Paul L. Gallant, Janice E. Kranz, Fariba Houman
  • Patent number: 5871987
    Abstract: The present invention relates to isolated and/or recombinant nucleic acids which encode Candida tyrosyl-tRNA synthetases, portions thereof, or fusion proteins comprising a Candida tyrosyl-tRNA synthetase or portion thereof. Also disclosed are constructs comprising the nucleic acids of the present invention, host cells comprising a recombinant nucleic acid or construct, and methods of producing a Candida tyrosyl-tRNA synthetase, portion thereof, or fusion protein comprising same. Also described are tester strains, which are cells engineered to rely on the function of a Candida tyrosyl-tRNA synthetase or functional fragment thereof encoded by an introduced cloned gene, and which can be used in a method of detecting an inhibitor of Candida tyrosyl-tRNA synthetase function.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: February 16, 1999
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Mandana Sassanfar, Paul L. Gallant, Xiaoyu Shen, Nianjun Tao, Jianshi Tao, Fariba Houman
  • Patent number: 5798240
    Abstract: Isolated and/or recombinant nucleic acids encoding mycobacterial methionyl-tRNA synthetase have been characterized. Recombinant DNA constructs and vectors having a sequence which encodes mycobacterial methionyl-tRNA synthetase have been made, and can be used for the construction of tester strains as well as for the production of isolated and/or recombinant methionyl-tRNA synthetases. These enzymes or portions thereof are useful in the biochemical separation of methionine and quantification of methionine or ATP, and for producing antibodies useful in the purification and study of the enzyme, for example. Host cells and methods useful for producing recombinant mycobacterial methionyl-tRNA synthetases are described, as are tester strains, which are cells engineered to rely on the function of the tRNA synthetase encoded by an introduced cloned gene.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: August 25, 1998
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Susan A. Martinis, Mandana Sassanfar, Sunghoon Kim, Sang Ho Lee, Paul R. Schimmel
  • Patent number: 5756327
    Abstract: Isolated and/or recombinant nucleic acids encoding mycobacterial isoleucyl-tRNA synthetase have been characterized. Recombinant DNA constructs and vectors having a sequence which encodes mycobacterial isoleucyl-tRNA synthetase have been made, and can be used for the construction of tester strains as well as for the production of isolated and/or recombinant isoleucyl-tRNA synthetases. These enzymes or portions thereof are useful in the biochemical separation of isoleucine and quantification of isoleucine or ATP, and for producing antibodies useful in the purification and study of the enzyme, for example. Host cells and methods useful for producing recombinant mycobacterial isoleucyl-tRNA synthetases are described, as are tester strains, which are cells engineered to rely on the function of the tRNA synthetase encoded by an introduced cloned gene.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: May 26, 1998
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Mandana Sassanfar, Paul R. Schimmel